We also previously demonstrated that, in Ang II-dependent kidney damage, the AT1 receptor block prevented a blood pressure increase and the production of reactive oxygen species; the empagliflozin treatment did not affect blood pressure and had a small effect on kidney damage. This evidence concerns the gene AGTR1 and Nephropathy.